Lorlatinib is a type of drug that’s like the third generation of ALK and ROS1 inhibitors. It’s used for a specific kind of lung cancer that’s spread and has already been treated with other ALK inhibitors. It works by going after these ALK and ROS1 things to stop the cancer from growing.
You can get this med in two strengths: 25 mg and 100 mg, both in these coated tablets. The usual dose is 100 mg, taken every day, and you can take it with or without eating. These tablets come in bottles with 30 in each.
